Spineology to distribute BioDlogics products derived from amniotic tissue

        Spineology website    BioDlogics website Spineology to Distribute BioDlogics Products (press release)

Spineology Inc., the innovator in anatomy conserving surgery technologies, today announced that it has entered into an agreement with BioDlogics to distribute that company’s line of allograft tissue forms. “Spineology’s corporate focus on minimally invasive surgical techniques coupled with its growing direct sales force provides an attractive opportunity for us to expand our penetration in a growing market segment” “BioDlogics’ products provide a very attractive complement to our current product line,” said John Booth, CEO for Spineology. “We believe that recent advances in regenerative medicine have the potential to significantly improve patient outcomes in numerous clinical applications. We look forward to working with BioDlogics to offer its line of novel allograft tissue to surgeons using our products.” “Spineology’s corporate focus on minimally invasive surgical techniques coupled with its growing direct sales force provides an attractive opportunity for us to expand our penetration in a growing market segment,” said Greg Brophy, president of BioDlogics. “We...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top